Search clinical trials for: epirubicin hydrochloride

Total 7649 results

Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Zhejiang Cancer Hospital

Not yet recruiting

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (ASCERTAIN)

Non-muscle Invasive Bladder Cancer

China
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
Nordic Society of Gynaecological Oncology - Clinical...
European Organisation for Research and Treatment of Cancer - EORTC

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Endometrial Cancer

France, Norway, Belgium, Spain, Netherlands, Italy, United Kingdom, Ireland, Poland, Portugal, South Africa
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
NCIC Clinical Trials Group

Completed

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Breast Cancer | Neutropenia

Canada
Trans Tasman Radiation Oncology Group
The Royal Australian and New Zealand College of Radiologists

Completed

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

Gastric Cancer

Australia, New Zealand
Medical University of South Carolina

Terminated

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach

Gastric Cancer

France
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Liver Cancer | Extrahepatic Bile Duct Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Cancer Trials Ireland

Completed

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Breast Cancer

Ireland
Lagos State University

Unknown

The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients

Haematological Abnormality

Nigeria
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

China
Case Comprehensive Cancer Center

Completed

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Gastric Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
University of Thessaly

Recruiting

Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) (GENSA)

Bladder Cancer

Greece
Nordic Society of Gynaecological Oncology - Clinical...
European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...

Completed

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Italy, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
IRCCS San Raffaele

Completed

Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer (PACT-7)

Pancreatic Cancer

Italy
Medical Research Council

Unknown

Combination Chemotherapy in Treating Patients With Esophageal Cancer

Esophageal Cancer

United Kingdom
Medical Research Council

Completed

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Gastric Cancer

United Kingdom
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Gastric Cancer | Esophageal Cancer

United States
Mansoura University

Completed

Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

Neoplasm, Bladder | Neoplasm, Ureter

Egypt
IRCCS San Raffaele

Completed

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer (PACT-9)

Pancreatic Cancer

Italy
Royal Marsden NHS Foundation Trust

Completed

Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer

Breast Cancer

United Kingdom
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen

Terminated

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

KRAS Wild Type | Resectable Type II Gastric Adenocarcinoma

Austria
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Breast Cancer

Switzerland
Zhimin Shao
Roche Pharma AG

Unknown

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

HER-2 Positive Breast Cancer

China
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients (ACCRUE)

Non-muscle Invasive Bladder Cancer

China
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Liver Cancer

United States
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer

Gastric Cancer

Switzerland
Mayo Clinic
National Cancer Institute (NCI)

Completed

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Breast Cancer
Cancer Research Campaign Clinical Trials Centre

Unknown

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery

Breast Cancer

United Kingdom
Australasian Gastro-Intestinal Trials Group
National Health and Medical Research Council, Australia; European Organisation... and other collaborators

Active, not recruiting

Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma (TOPGEAR)

Gastric Cancer

Australia, New Zealand
Pfizer

Completed

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Adenocarcinoma

United States
The Christie NHS Foundation Trust

Unknown

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Carcinoma of Unknown Primary

United Kingdom
Heinrich-Heine University, Duesseldorf

Unknown

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Breast Cancer

Germany
Fudan University

Completed

Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

Breast Cancer

China
UNICANCER

Completed

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Lung Cancer

France
European Organisation for Research and Treatment...

Terminated

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Gastric Cancer | Adenocarcinoma of the Gastroesophageal Junction

Belgium, Portugal, Germany
UNICANCER

Completed

Combination Chemotherapy in Treating Women With Stage I Breast Cancer

Breast Cancer

France
Centro di Riferimento Oncologico - Aviano

Unknown

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

Lymphoma

Italy

3

Subscribe